Adenosine Phosphate

Adenosine Phosphate

SCHEMBL1338615

Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O.Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY1 P47900 5/20 1.00
P2RY2 P41231 3/20 1.00
SRC P12931 2/20 1.00
SMN1; SMN2 Q16637 2/20 1.00
TRPM2 O94759 2/20 1.00
TAS1R3 Q7RTX0 2/20 1.00
TAS1R1 Q7RTX1 2/20 1.00
DNPH1 O43598 1/20 1.00
PRKAB2 O43741 1/20 1.00
LDHA P00338 1/20 1.00
ADRB2 P07550 1/20 1.00
FBP1 P09467 1/20 1.00
ADORA1 P30542 1/20 1.00
PRKAG1 P54619 1/20 1.00
PRKAA2 P54646 1/20 1.00
PDE4D Q08499 1/20 1.00
KCNH2 Q12809 1/20 1.00
PRKAA1 Q13131 1/20 1.00
PDE3A Q14432 1/20 1.00
P2RY11 Q96G91 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Adenosine Phosphate SCHEMBL13374692 1.00 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL20277555 1.00 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL14478782 1.00 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL144997 1.00 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL13170051 1.00 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL19420134 1.00 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL11977309 1.00 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL8572634 1.00 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL132458 1.00 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL15646670 1.00 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110233623-B Circuit applied to MDAC for calibrating common-mode voltage 北京时代民芯科技有限公司 2023-04-14 CN claimed
CN-106030078-B The method for determining atmospheric pressure of the turbocharged engine during the operation under part load condition 法国大陆汽车公司 2019-09-06 CN claimed
CN-107271471-A The extraction of monoesters phosphorus component and phosphorus nuclear magnetic resonance spectrum figure analysis method in a kind of lake sediment 中国环境科学研究院 2017-10-20 CN claimed
US-9744236-B2 Photolabile compounds THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2017-08-29 US claimed
CN-106030078-A Method for determining atmospheric pressure during the operation, in a partial load state, of a turbocharged engine 法国大陆汽车公司 2016-10-12 CN claimed
CN-103554142-B The preparation method of nucleotide rare earth coordination polymer luminescent material 东南大学 2016-06-29 CN claimed
CN-103554142-A Preparation method of nucleotide-rare earth coordination polymer light-emitting material UNIV SOUTHEAST 2014-02-05 CN claimed
US-20120220922-A1 PHOTOLABILE COMPOUNDS UNIVERSIDAD DE BUENOS AIRES (AR) 2012-08-30 US claimed
US-20120116287-A1 PHOTOLABILE COMPOUNDS UNIVERSIDAD DE BUENOS AIRES (AR) 2012-05-10 US claimed
EP-2445917-A1 PHOTOLABILE COMPOUNDS The Trustees of Columbia University in the City of New York (US) 2012-05-02 EP claimed
US-8063216-B2 have a photoreleasable ligand, which can be biologically active, and which is photoreleased from the compound upon exposure to light THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2011-11-22 US claimed
WO-2010151879-A1 PHOTOLABILE COMPOUNDS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2010-12-29 WO claimed
US-20080176940-A1 Photolabile Compounds THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2008-07-24 US claimed
WO-2005065192-A2 PHOTOLABILE COMPOUNDS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2005-07-21 WO claimed
CN-114630911-B Enzymatic process for the preparation of UDP-GlcNAc 马克斯·普朗克科学促进学会 2024-06-28 CN disclosed
WO-2024043266-A1 DATA ACQUISITION CIRCUIT AND BIOSENSOR 日東電工株式会社 2024-02-29 WO disclosed
US-11767546-B2 Enzymatic method for preparation of UDP-GlcNAc MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2023-09-26 US disclosed
US-4464834-A Methods of use of distribution modules for multi-wire group interconnection in telephone or like multi-wire distribution systems GRAYBEAL, JOHN O., 4298 SHORECLUB DRIVE S.E., MERCER ISLAND, WA. 98040 1984-08-14 US disclosed
US-4419532-A Thermophotovoltaic power source THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 1983-12-06 US disclosed
US-4298968-A Digital reflection searching and section plotting MOBIL OIL CORPORATION (US) 1981-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120220922-A1 PHOTOLABILE COMPOUNDS VIP, EPCAM, L1CAM P2RY1 83/4885P2RY2 124/4885SRC 1443/4885
US-20120116287-A1 PHOTOLABILE COMPOUNDS HMBS, CASP3, CRY1 P2RY1 205/4885P2RY2 326/4885SRC 1602/4885
US-20080176940-A1 Photolabile Compounds HMBS, CASP3, CRY1 P2RY1 205/4885P2RY2 326/4885SRC 1602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.